Advisory Research Inc. maintained its stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,106 shares of the company’s stock at the end of the second quarter. Advisory Research Inc.’s holdings in Cardinal Health were worth $5,472,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Cubist Systematic Strategies LLC purchased a new position in shares of Cardinal Health during the 2nd quarter worth about $1,216,000. BlueCrest Capital Management Ltd purchased a new position in shares of Cardinal Health during the 2nd quarter worth about $517,000. Shelton Capital Management purchased a new position in shares of Cardinal Health during the 2nd quarter worth about $238,000. Sii Investments Inc. WI purchased a new position in shares of Cardinal Health during the 2nd quarter worth about $594,000. Finally, Zurich Insurance Group Ltd FI lifted its holdings in shares of Cardinal Health by 14.3% during the 2nd quarter. Zurich Insurance Group Ltd FI now owns 60,921 shares of the company’s stock worth $4,747,000 after acquiring an additional 7,599 shares during the period. Institutional investors and hedge funds own 87.98% of the company’s stock.

Cardinal Health, Inc. (NYSE CAH) traded up 1.0784% on Tuesday, reaching $65.6201. 227,805 shares of the company traded hands. The stock has a market capitalization of $20.77 billion, a price-to-earnings ratio of 16.2829 and a beta of 0.86. Cardinal Health, Inc. has a 52-week low of $62.70 and a 52-week high of $84.88. The firm has a 50 day moving average price of $67.19 and a 200 day moving average price of $73.19.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.14 EPS. Equities research analysts predict that Cardinal Health, Inc. will post $4.95 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be issued a dividend of $0.4624 per share. The ex-dividend date is Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.85%. Cardinal Health’s dividend payout ratio is 45.79%.

Several research analysts have recently weighed in on the stock. Evercore ISI reiterated an “outperform” rating on shares of Cardinal Health in a report on Tuesday, July 4th. UBS AG reiterated a “neutral” rating and set a $76.00 price objective (down from $79.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Vetr upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $77.92 price objective on the stock in a report on Tuesday, June 13th. Needham & Company LLC reiterated a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Finally, Cowen and Company reiterated a “market perform” rating and set a $77.00 price objective (down from $82.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company. Cardinal Health has a consensus rating of “Hold” and an average price target of $76.81.

TRADEMARK VIOLATION WARNING: “Cardinal Health, Inc. (CAH) Holdings Maintained by Advisory Research Inc.” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.watchlistnews.com/cardinal-health-inc-cah-holdings-maintained-by-advisory-research-inc/1621666.html.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.